Editas Medicine, Inc.(EDIT)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
EDIT | 457.3 M | -2.61x | -39.20% | -2.82% | $-1.14 | -3.26% | 3.92 | - | $4.54 | $1.66 |
ZURA | 517.1 M | -5.00x | - | - | $-1.09 | -40.96% | - | - | $7.44 | $1.00 |
EBS | 393.7 M | -40.16x | -29.70% | -1.27% | $-0.19 | -1.60% | 1.12 | - | $14.06 | $5.62 |
XFOR | 360.3 M | -1.85x | -90.60% | - | $-2.07 | -1.04% | 0.46 | - | $4.83 | $1.35 |
CYDY | 287.6 M | -5.25x | - | - | $-0.04 | - | - | - | $0.40 | $0.21 |
Peer Valuation & Performance Analysis
Peer group analysis for Editas Medicine, Inc. (EDIT) compared to its primary competitors (including ZURA, EBS, XFOR) reveals distinct metrics. EDIT trades at a valuation premium compared to its competitors, with a P/E ratio of -2.6x versus the peer average of -13.1x (representing a -80% premium). This indicates that the market expects superior growth or commands a quality premium for EDIT. In terms of growth, EDIT's revenue growth of -39.2% exceeds the peer average of -60.2%, highlighting its competitive strength and market share gains. Additionally, its net margin of -2.8% is comparable to the peer average of -1.3%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• EDIT ranks #0 in P/E ratio, #4 in revenue growth, and #5 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-07-17 | $2.80 | $3.02 | $2.77 | $2.98 | 1,748,800 | +6.43% |
| 2026-07-16 | $3.00 | $3.01 | $2.82 | $2.88 | 1,385,700 | -4.00% |
| 2026-07-15 | $3.15 | $3.17 | $2.99 | $3.04 | 1,596,465 | -3.49% |
| 2026-07-14 | $3.18 | $3.21 | $3.05 | $3.16 | 1,843,200 | -0.63% |
| 2026-07-13 | $3.19 | $3.19 | $3.04 | $3.16 | 2,067,000 | -0.94% |
| 2026-07-10 | $3.27 | $3.28 | $2.96 | $3.26 | 3,588,200 | -0.31% |
| 2026-07-09 | $3.65 | $3.72 | $3.26 | $3.30 | 3,488,700 | -9.59% |
| 2026-07-08 | $3.69 | $3.81 | $3.62 | $3.67 | 2,454,800 | -0.54% |
| 2026-07-07 | $3.65 | $3.81 | $3.52 | $3.75 | 2,817,000 | +2.74% |
| 2026-07-06 | $3.60 | $3.79 | $3.55 | $3.65 | 2,949,900 | +1.39% |
| 2026-07-02 | $3.33 | $3.68 | $3.32 | $3.65 | 4,202,100 | +9.61% |
| 2026-07-01 | $3.24 | $3.48 | $3.13 | $3.28 | 2,983,900 | +1.23% |
| 2026-06-30 | $3.19 | $3.27 | $3.11 | $3.24 | 1,843,200 | +1.57% |
| 2026-06-29 | $2.87 | $3.23 | $2.87 | $3.20 | 3,037,500 | +11.50% |
| 2026-06-26 | $2.76 | $2.94 | $2.72 | $2.85 | 6,394,400 | +3.26% |